DE EN Anmelden

In your studies 'Drug Regulator Affairs'

©Volker Lannert / Universität Bonn

Master's thesis


As part of the continuing education Master's degree programme, Master's theses are written on relevant topics in the field of 'Drug Regulatory Affairs' using scientific methods. The topics are highly topical, diverse and the results are both of interest in a scientific context and relevant to many areas of activity in 'Drug Regulatory Affairs'.

Here you will find all Master's theses written since the year 2000, including the title and a summary. In this collection, many Master's theses can also be viewed and downloaded in full text.

Further information on Master's theses (e.g. registration, processing) can be found in our ‘Master's thesis guidelines/Leitfaden für die Anfertigung einer Masterarbeit’ (in German) and in the ‘Information leaflet - Master's thesis’ at

Downloads from A-Z

Do you have any questions or are you interested in the full text of a Master's thesis that is not listed here?
Please feel free to contact me.

Dr. Jasmin Fahnenstich

Dr. Jasmin Fahnenstich

Study programme manager

Phone: +49 (0) 228 - 9268 6806

Send e-mail

Master's thesis

The collection of Master's theses can be searched and sorted by entering keywords.

Year Name Title Full text Summary
2010 Syed Irshad Rizvi Influenza A (H1N1) - a new communicable disease Role and activities of the Health Authorities and International Organizations in relation to the current H1N1 influenza pandemic ***
2010 Dr. Johanna Roggemann An overview on the requirements for the acceptability of invented names for human medicinal products in the Centralised Procedure ***
2010 Dr. Christiane Rothkegel Impact of Clinical Trial Registration on the Future of Drug Research ***
2010 Ridwan Sarwin Assessment of the new EU variation regulation No 1234/2008/EC on the practicality aspects for post-approval changes of human medicinal products
2010 Dr. Erik Schneider Determination and comparison of the regulatory requirements of human recombinant antibodies, Fab-fragments and aptamers regarding product and manufacturing quality
2010 Dr. Stephanie Schwarz Make off-patent drugs available to children: Regulatory approaches in Europe and the US ***
2010 Dr. Dietmar Theisen European Regulatory Framework of Stem Cell-based Medicinal Products ***
2010 Anna Volodina Clinical Studies in Eastern Europe: critical assessment of the regulatory requirements ***
2010 Dr. Claudia Karin Wagner Distribution restrictions (Re-switch of OTC medicines) in Germany and in other selected countries ***
2010 Sabine Wolf European and German Regulatory Requirements to the Design and Validation of Nucleic Acid Tests for Blood Screening ***
2010 Henny Anna Zietze Involvement of Patients’ and Consumers’ Organisations (PCOs) in activities of the EMA: Development, implementation and outlook ***
2010 Dr. Karl Zimmermann Die gewerblichen Schutzrechte bei Arzneimitteln in der Europäischen Union und den USA – Arzneimittel und Patente
2010 Michael Zlottchenko The Quality and Safety Requirements for Vaccines with Emphasis on Viral Vaccines from a Global Point of View
2009 Stephan Becker Regulatory Considerations on Drug Interaction Studies ***
2009 Dr. Claus-Peter Danzer Borderline Situations and other important Aspects for the Regulatory Work with Medicinal Products for Oral Care in Europe
2009 Dr. Birgit Dziadek, geb. Kranke Generic Substitution of Medicinal Products in the European Economic Area ***
2009 Alice Ebel Due diligence of R&D projects - A guideline for evaluating regulatory aspects ***
2009 Dr. Ulrich Feil Replacement, Reduction, Refinement of Animal Testing in Quality Control of Medicinal Products in the EU ***
2009 Sabina Freund-Rieger Market Exclusivity versus Market Penetration: Theory and Practice of Originator –Generic Competition ***
2009 Michael Hahn Die Auswirkungen der Arzneimittelrabattverträge nach dem GKV-Wettbewerbsstärkungsgesetz auf den deutschen Generikamarkt
  • Total: 955